Delivery Order SPE2DR25D3004-SPE2DR26FXRB5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,113.32 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. This non-competitive delivery order was issued on November 24, 2025, with a completion date of November 25, 2025, and reflects a firm fixed price contract structure. The award was fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,028.29 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract, which is not set-aside, was awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, under firm fixed-price terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.99 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 19, 2025. The award was issued on December 18, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Januvia 100 mg tablets (1,000 count) under a firm fixed-price contract valued at $22,743.64. The order is scheduled for completion by December 12, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.55 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Januvia 100 mg tablets (90-count packages). This is a firm fixed price delivery order with an ultimate completion date of November 14, 2025, and represents a non-competitive set-aside award. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $20,619.44 to supply 90 tablets of Januvia 100 mg, a medication used in diabetes management. This is a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and represents a non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,608.00 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg on December 16, 2025, with an ultimate completion date of December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The pharmaceutical product will be performed from the contractor's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,056.72. This non-set-aside, competitively awarded delivery order represents a firm fixed-price transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXRB5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,665.83 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical supply requirements through competitive awards across multiple therapeutic domains, including specialty medications, vaccines, and medical devices for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 12/17/25 |